Deep Tech Startups

Symetrica manufactures radiation detection and integrated threat detection systems for airport, port, military, and homeland security applications. The company provides handheld devices, portal monitors, X-ray integration platforms, and a software platform called Discovery Technology for operational command and control.

1 investor

Symmatrics provides quantum-secure encryption infrastructure that uses one-time symmetric keys generated from true random numbers to protect data in motion across industries such as healthcare, finance, e-commerce, gaming, and crypto. It offers a key-delivery layer and SDK that replace password-based identity and legacy PKI/certificate-based encryption without requiring application code changes, targeting enterprises, government agencies, and regulated sectors.

1 investor

SYMX.AI provides AI-powered monitoring, real-time reporting, and predictive maintenance solutions for mining operations and equipment fleets. The company develops industrial intelligence platforms that optimize equipment maintenance and operational efficiency across open-pit and underground mining sites.

1 investor

Synapse, part of Capgemini Invent, provides design and technology innovation services focused on sustainability and climate solutions. The company helps clients reduce product carbon footprints, develop climate technologies, and build circular economy capabilities across energy, transportation, agriculture, and built environments.

1 investor

Synaptrix is building a vertically integrated neuroAI platform that combines high-density non-invasive EEG hardware, large-scale neural datasets, and AI models built for brain signals. It develops non-invasive brain-computer interfaces and runs clinical studies for people with mobility and communication impairments.

1 investor

SynaXG develops O-RAN infrastructure software and solutions that combine artificial intelligence with 5G and next-generation wireless technologies for telecommunications providers. The company serves both public and private network customers with cloud RAN, distributed RAN, fixed wireless access, and enterprise private 5G network solutions.

1 investor

Synboli develops polymers using a combination of AI-powered design models and proprietary patented synthesis chemistry to speed up the discovery and testing of high-performance materials. It serves the polymer and material science industry, aiming to cut development time for new materials across sectors like textiles, construction, aerospace, transportation, and healthcare.

1 investor

SynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.

1 investor

Synergia Medical develops optoelectronic implantable medical devices, including its NAO.VNS vagus nerve stimulation system, which is undergoing First-In-Human clinical evaluation through the AURORA study. The company is based in Belgium.

1 investor

SynergyXR develops virtual and augmented reality tools that help professionals integrate XR technologies into their everyday work processes.

1 investor

Synex develops compact, portable technology that uses magnetic resonance spectroscopy to measure blood metabolites such as glucose and lactate non-invasively and in real time, without a needle prick. The company is building non-invasive health monitoring devices aimed at enabling predictive healthcare.

1 investor

Synmedchem provides synthetic chemistry and medicinal chemistry services for drug discovery and compound design, serving pharmaceutical and biotech clients globally with teams across Australia, China, North America, the UK, and Europe.

1 investor

Synonym is an applied research lab that uses AI to launch autonomous consumer brands, validating product concepts through simulations run against a population of consumer digital twins and converting top performers into real brands. It operates as an AI-native "brand factory" in the consumer goods space.

1 investor

Synovus designs Automated Test Equipment (ATE) that combines hardware and software to help clients test, diagnose, and understand their prototypes during research and development. It works with clients to deliver customizable testing solutions built on its Symplify and SBX platforms.

1 investor

Synth-Med develops a drug delivery platform that uses red blood cells to encapsulate therapeutic payloads in nanoparticles and target hard-to-reach tissues, with a lead program delivering a memory-enhancing molecule to the brain for Alzheimer's and other neurodegenerative diseases. The company operates in the biotech and therapeutics sector.

1 investor

SynthBiome designs synthetic growth media that replicate the physiological conditions bacterial pathogens encounter in human infection sites, including media mimicking cystic fibrosis sputum and chronic wound environments. Its models serve researchers and clinical teams for drug development and antibiotic treatment selection.

1 investor

Synthio Chemicals develops advanced manufacturing processes for fine chemicals, using process intensification, scale-up, and automation to deliver scalable production processes for client firms. The company acts as a development partner offering consultations on custom chemical manufacturing.

1 investor

Synthium generates human-robot interaction data for humanoid robots by having people interact with robots in live simulations, capturing motion, voice, language, and decisions as labeled training data. It serves robotics teams building Vision-Language-Action (VLA) models who need interactive, multimodal datasets for embodied AI.

1 investor

Syntropi provides rights-cleared, real-world video datasets for training frontier video and world models, sourcing long-form and egocentric footage through contracted contributors. It verifies and structures the footage via a proprietary ML pipeline, delivering training-ready datasets with clear provenance to AI model developers.

1 investor

Syrna Therapeutics is a biotech company developing small-molecule covalent translation inhibitors that bind and modify structured domains in the mRNA of disease-causing proteins to block their expression. It uses a 3D structure-guided drug discovery platform, with lead programs in immunology and neurodegeneration and a broader pipeline spanning metabolic disease and oncology.

1 investor

Systellar provides a design platform called synapse that enables model-based systems engineering for complex physical systems, offering unified workspace for design, requirements management, documentation, and workflow automation with version control and traceability capabilities.

1 investor

A compound-semiconductor company operating a vertically integrated IDM platform covering chip design, epitaxial growth, wafer fabrication, and device packaging/testing for third-generation photonic chips. It develops InP-based high-speed laser chips (FP/DFB/EML series, including 100Gbps PAM4 EML and CW-DFB) for optical communications applications such as FTTH, backbone networks, 5G transport, hyperscale data centers, autonomous driving, and industrial IoT.

1 investor

t1 is a cross-chain liquidity and interoperability protocol that uses trusted execution environments (TEEs) and real-time proving to enable composable applications across the EVM/Ethereum ecosystem. It provides developers with cross-chain composability, permissionless interop, and products such as an RTP bridge for faster, cheaper bridging.

1 investor

Taara provides high-capacity wireless connectivity designed to extend internet access across challenging terrain, growing communities, and crisis situations without the need for extensive physical infrastructure. It serves communities, businesses, and individuals needing reliable network capacity during growth, remote deployment, infrastructure failure, or demand spikes.

1 investor